COSCIENS Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 204.5%.

Top 16 shareholders own 7.75% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.99%	GoodWood Inc.	221,570	CA$937.2k	24%	16.99%
0.98%	Gilles Gagnon	36,062	CA$152.5k	0%	no data
0.16%	Prodev Pharma Inc	5,900	CA$25.0k	0%	no data
0.16%	National Bank Investments Inc.	5,796	CA$24.5k	587%	no data
0.12%	Fédération des Caisses Desjardins du Québec, Asset Management Arm	4,536	CA$19.2k	-8.12%	no data
0.1%	Toronto-Dominion Bank, Banking Investments	3,717	CA$15.7k	0%	no data
0.068%	RBC Dominion Securities Inc., Asset Management Arm	2,527	CA$10.7k	-3.37%	no data
0.065%	William Li	2,397	CA$10.1k	0%	no data
0.05%	Ulrich Kosciessa	1,848	CA$7.8k	0%	no data
0.024%	Geode Capital Management, LLC	897	CA$3.8k	-4.47%	no data
0.021%	Stacy Prefontaine	767	CA$3.2k	0%	no data
0.0087%	Dennis Turpin	320	CA$1.4k	0%	no data
0.0014%	Osaic Wealth, Inc. , Asset Management Arm	50	CA$211.1	0%	no data
0.001%	Tower Research Capital Europe Limited	38	CA$161.1	8.57%	no data
0.0006%	Truvestments Asset Management LLC	22	CA$93.8	0%	no data
0.00005%	Planning Capital Management Corp.	2	CA$7.8	0%	no data